-
公开(公告)号：US11931589B2
公开(公告)日：2024-03-19
申请号：US17012745
申请日：2020-09-04
Applicant: Medtronic, Inc.
Inventor： James K. Carney , Saul E. Greenhut , Jonathan L. Kuhn , James D. Reinke , David J. Peichel , James W. Busacker
IPC: A61N1/372 , A61B5/00 , A61B5/29 , A61N1/365 , A61N1/39 , H04B13/00 , A61N1/362 , A61N1/368 , A61N1/375
CPC classification number: A61N1/37288 , A61B5/0031 , A61B5/29 , A61B5/4836 , A61N1/365 , A61N1/37276 , A61N1/3925 , A61N1/3962 , H04B13/005 , A61B5/0024 , A61B5/7282 , A61B2560/0209 , A61N1/3627 , A61N1/3684 , A61N1/37205 , A61N1/3756
Abstract: Systems, devices, and techniques for establishing communication between two medical devices are described. In one example, an implantable medical device comprises communication circuitry, therapy delivery circuitry, and processing circuitry configured to initiate a communication window during which the implantable second medical device is capable of receiving the information related to a cardiac event detected by a first medical device, the communication window being one of a plurality of communication windows defined by a communication schedule that corresponds to a transmission schedule in which the first medical device is configured to transmit the information, control the communication circuitry to receive, from the first medical device, the information related to the cardiac event that is indicative of a timing of the cardiac event with respect to a timing of the communication window, schedule and control delivery of a therapy according to the information related to the cardiac event.
-
42.发明公开公开(公告)号：US20230404446A1
公开(公告)日：2023-12-21
申请号：US18460271
申请日：2023-09-01
Applicant: Medtronic, Inc.
Inventor： Daniel Hahn , Mohsen Askarinya , James K. Carney , Patrick W. Kinzie , Jennifer Lorenz Marckmann , Randal C. Schulhauser , Santhisagar Vaddiraju , Akhil Srinivasan , David Probst , Alejo Chavez Gaxiola
IPC: A61B5/1468 , A61B5/053 , A61B5/145
CPC classification number: A61B5/1468 , A61B5/053 , A61B5/14532 , A61B5/14546 , A61B5/1486
Abstract: A biocompatible medical device may include an electrochemical sensor including a common reference electrode; at least one counter electrode; and a work electrode platform comprising a plurality of respective work electrodes, each respective work electrode electrically coupled to the common reference electrode and comprising a respective reagent substrate configured to react with a respective analyte to produce a respective signal indicative of a concentration of the respective analyte; and processing circuitry operatively coupled to the electrochemical sensor, and configured to receive from the electrochemical sensor a plurality of signals from the plurality of respective work electrodes; identify the respective signal corresponding to a respective selected work electrode; and process the identified signal to determine the concentration of the respective analyte associated with the respective selected work electrode.
-
公开(公告)号：US11684775B2
公开(公告)日：2023-06-27
申请号：US16686617
申请日：2019-11-18
Applicant: Medtronic, Inc.
Inventor： Michael D. Eggen , James K. Carney , Matthew D. Bonner , Vladimir Grubac , Douglas S. Hine , Thomas D. Brostrom , John L. Sommer
CPC classification number: A61N1/057 , A61N1/3756 , A61N1/37518
Abstract: A relatively compact implantable medical device includes a fixation member formed by a plurality of fingers mounted around a perimeter of a distal end of a housing of the device; each finger is elastically deformable from a relaxed condition to an extended condition, to accommodate delivery of the device to a target implant site, and from the relaxed condition to a compressed condition, to accommodate wedging of the fingers between opposing tissue surfaces at the target implant site, wherein the compressed fingers hold a cardiac pacing electrode of the device in intimate tissue contact for the delivery of pacing stimulation to the site. Each fixation finger is preferably configured to prevent penetration thereof within the tissue when the fingers are compressed and wedged between the opposing tissue surfaces. The pacing electrode may be mounted on a pacing extension, which extends distally from the distal end of the device housing.
-
公开(公告)号：US20220323007A1
公开(公告)日：2022-10-13
申请号：US17808924
申请日：2022-06-24
Applicant: Medtronic, Inc.
Inventor： Jonathan L. Kuhn , James K. Carney , Vinod Sharma , Shantanu Sarkar , Todd M. Zielinski , Tommy D. Bennett
IPC: A61B5/00 , A61B5/0205 , A61B5/07 , A61B5/1455 , A61B5/1459 , A61B5/287
Abstract: In some examples, determining a heart failure status includes using an implantable medical device configured for subcutaneous implantation and comprising a plurality of electrodes and an optical sensor. Processing circuitry of a system comprising the device may determine, for a patient, a current tissue oxygen saturation value based on a signal received from the at least one optical sensor, a current tissue impedance value based on a subcutaneous tissue impedance signal received from the electrodes, and a current pulse transit time value based on a cardiac electrogram signal received from the electrodes and at least one of the signal received from the optical sensor and the subcutaneous tissue impedance signal. The processing circuitry may further compare the current tissue oxygen saturation value, current tissue impedance value, and current pulse transit time value to corresponding baseline values, and determine the heart failure status of the patient based on the comparison.
-
45.发明授权公开(公告)号：US10828494B2
公开(公告)日：2020-11-10
申请号：US15813189
申请日：2017-11-15
Applicant: Medtronic, Inc.
Inventor： Scott A. Hareland , James K. Carney , James D. Reinke , Jon D. Schell , Barbara J. Schmid
Abstract: An implantable medical device comprising a signal generator configured to generate and deliver anti-tachyarrhythmia pacing (ATP) to a heart of a patient and processing circuitry. The processing circuitry is configured to detect an enable event, responsive to detecting the enable event, enable the delivery of ATP by the signal generator, detect a disable event indicating that another implantable medical device cannot be relied upon to deliver an anti-tachyarrhythmia shock, and responsive to detecting the disable event, disable delivery of ATP.
-
Patent Agency Ranking
公开(公告)号：US10773088B2
公开(公告)日：2020-09-15
申请号：US15484430
申请日：2017-04-11
Applicant: Medtronic, Inc.
Inventor： James K. Carney , Saul E. Greenhut , Jonathan L. Kuhn , James D. Reinke , David J. Peichel , James W. Busacker
IPC: A61N1/372 , A61N1/365 , A61N1/39 , A61B5/00 , H04B13/00 , A61N1/368 , A61N1/375 , A61B5/042 , A61N1/362
Abstract: Systems, devices, and techniques for establishing communication between two medical devices are described. In one example, an implantable medical device comprises communication circuitry, therapy delivery circuitry, and processing circuitry configured to initiate a communication window during which the implantable second medical device is capable of receiving the information related to a cardiac event detected by a first medical device, the communication window being one of a plurality of communication windows defined by a communication schedule that corresponds to a transmission schedule in which the first medical device is configured to transmit the information, control the communication circuitry to receive, from the first medical device, the information related to the cardiac event that is indicative of a timing of the cardiac event with respect to a timing of the communication window, schedule and control delivery of a therapy according to the information related to the cardiac event.
-
公开(公告)号：US10765790B2
公开(公告)日：2020-09-08
申请号：US15969030
申请日：2018-05-02
Applicant: Medtronic, Inc.
Inventor： Aleksandre T. Sambelashvili , David A. Anderson , James K. Carney , David M. Steinhaus , Narendra K. Simha
Abstract: An example pump thrombosis detection system includes a transducer and processing circuitry. The transducer may be configured to generate a signal representative of a mechanical wave from a mechanical circulatory support device. The processing circuitry is communicatively coupled to the transducer. The processing circuitry may be configured to determine an indication of pump thrombosis based on the signal and, based on the indication of pump thrombosis, control the pump thrombosis detection system to at least one of generate an alert or initiate an intervention.
-
公开(公告)号：US20200078585A1
公开(公告)日：2020-03-12
申请号：US16686617
申请日：2019-11-18
Applicant: Medtronic, Inc.
Inventor： Michael D. Eggen , James K. Carney , Matthew D. Bonner , Vladimir Grubac , Douglas S. Hine , Thomas D. Brostrom , John L. Sommer
Abstract: A relatively compact implantable medical device includes a fixation member formed by a plurality of fingers mounted around a perimeter of a distal end of a housing of the device; each finger is elastically deformable from a relaxed condition to an extended condition, to accommodate delivery of the device to a target implant site, and from the relaxed condition to a compressed condition, to accommodate wedging of the fingers between opposing tissue surfaces at the target implant site, wherein the compressed fingers hold a cardiac pacing electrode of the device in intimate tissue contact for the delivery of pacing stimulation to the site. Each fixation finger is preferably configured to prevent penetration thereof within the tissue when the fingers are compressed and wedged between the opposing tissue surfaces. The pacing electrode may be mounted on a pacing extension, which extends distally from the distal end of the device housing.
-
公开(公告)号：US20190336077A1
公开(公告)日：2019-11-07
申请号：US15969407
申请日：2018-05-02
Applicant: Medtronic, Inc.
Inventor： Jonathan L. Kuhn , James K. Carney , Shantanu Sarkar
IPC: A61B5/00 , A61B5/0205 , A61B5/07 , A61B5/1455 , A61B5/1459 , A61B5/042
Abstract: In some examples, determining a health status includes using an implantable medical device configured for subcutaneous implantation and comprising at least one optical sensor. Processing circuitry of a system comprising the device may determine, for a patient, a current tissue oxygen saturation value based on a first signal received from the at least one optical sensor and a current pulsatile oxygen saturation value based on a second signal received from the at least one optical sensor. The processing circuitry may further compare the current tissue oxygen saturation and current pulsatile oxygen saturation values to corresponding baseline values, determine corresponding heart failure and pulmonary statuses of the patient based on the comparisons, and determine the health status of the patient based on the statuses.
-
公开(公告)号：US20190336076A1
公开(公告)日：2019-11-07
申请号：US15969369
申请日：2018-05-02
Applicant: Medtronic, Inc.
Inventor： Jonathan L. Kuhn , James K. Carney , Vinod Sharma , Shantanu Sarkar , Todd M. Zielinski , Tommy D. Bennett
IPC: A61B5/00 , A61B5/0205 , A61B5/042 , A61B5/07 , A61B5/1455 , A61B5/1459
Abstract: In some examples, determining a heart failure status includes using an implantable medical device configured for subcutaneous implantation and comprising a plurality of electrodes and an optical sensor. Processing circuitry of a system comprising the device may determine, for a patient, a current tissue oxygen saturation value based on a signal received from the at least one optical sensor, a current tissue impedance value based on a subcutaneous tissue impedance signal received from the electrodes, and a current pulse transit time value based on a cardiac electrogram signal received from the electrodes and at least one of the signal received from the optical sensor and the subcutaneous tissue impedance signal. The processing circuitry may further compare the current tissue oxygen saturation value, current tissue impedance value, and current pulse transit time value to corresponding baseline values, and determine the heart failure status of the patient based on the comparison.
-
-
-
-
-
-
-
-
-
Search Results
55
records
(took 0.044 seconds)
